1D·

Top News Stories from the Past Week

Monday:


The Investment Summit kicks off, and $SAN (+0,1 %) Sanofi announces its first billion-euro investment in Frankfurt. An insulin plant is to be built by 2032.


https://www.handelsblatt.com/unternehmen/industrie/medizin-milliardenprojekt-sanofi-baut-neue-insulinfabrik-in-frankfurt/100263264.html?utm_source=hb-eveningbriefing&utm_medium=nl&utm_campaign=standard-free&utm_content=19102026


Tuesday:


For companies in Germany, the shortage of skilled workers remains the biggest challenge (73% of companies). The often-cited energy shortage comes in second at 57%. Bureaucracy is also a major challenge for many companies, at 49%.


https://www.handelsblatt.com/politik/konjunktur/investitionen-acht-grafiken-zeigen-die-wahre-lage-des-standorts-deutschland/100261531.html


$ADS (+1,73 %) Adidas raises its profit forecast. The world’s second-largest sporting goods manufacturer is expected to post an operating profit of 2.5 billion euros. Revenue also increased by more than 7% in the third quarter.


https://www.handelsblatt.com/unternehmen/handel-konsumgueter/quartalszahlen-adidas-erzielt-rekordergebnisse-und-hebt-gewinnprognose-an/100263709.html


Wednesday:


PHP vulnerabilities are driving up cybersecurity stocks such as $NET (+0,26 %) Cloudflare. Cloudflare fends off attackers before they can even reach the website.


https://de.investing.com/news/stock-market-news/kritische-phpsicherheitslucke-bedroht-70--aller-websites--cloudflare-und-cybersecurityaktien-legen-kraftig-zu-3715602


Friday:


A new $MRNA (-6,89 %) Moderna vaccine reduces the risk of dying from skin cancer by 42%. The risk of metastasis was also reduced by 38%. The vaccine is based on mRNA technology and is individually tailored.


https://m.bild.de/leben-wissen/medizin/durchbruch-in-grosser-studie-krebs-impfstoff-senkt-sterberisiko-um-42-prozent-6adb132cae90f8cf4e4bafc1

previw image
5
3 Comentarios

Imagen de perfil
It's good for the company where I worked for 45 years. The former Hoechst AG… those were the days. The pharmaceutical division became HMR, then Aventis, and was eventually acquired by Sanofi. As you can see, things can keep moving forward, even in Europe.
•
1
•
Imagen de perfil
A remarkably uneventful week for an entire planet.
••
Imagen de perfil
@Yoshika
But fortunately, the editorial staff hasn't lost sight of what's important...
••
Únase a la conversación